Abstract
Metronidazole-resistant H. pylori associating with mutations of rdxA or frxA is still a debated topic. This study investigates whether rdxA and frxA mutations of H. pylori accounted for the high MIC value (>/= 64 micro g/ml) of metronidazole (Mtz). From 126 clinical H. pylori isolates, we examined 14 Mtz-sensitive, 18 Mtz-resistant H. pylori, and eight pairs of Mtz-sensitive and Mtz-resistant colonies simultaneously present within a single gastric biopsy. The paired strains from one single biopsy were proven identical by PCR-RFLP. MICs of Mtz were checked by the E-test and agar dilution method. The mutations of rdxA and frxA sequencing were matched with the Mtz-susceptible ATCC 26695 and J99. There were 89% (16/18) of Mtz-resistant isolates with mutation of RdxA. Half of the 14 Mtz-sensitive strains, all without mutation of RdxA, still contained truncation of FrxA. Within the paired isolates from a single biopsy, rdxA mutation (86%) was more common than frxA mutation (43%) in those isolates with high-level Mtz-resistant H. pylori. RdxA truncation was more prevalent in Mtz-resistant strains with high MICs than in those with low to moderate MICs (75% vs. 20%, p =.01, OR: 12, 95% CI: 1.8-81.7). Mutations in the rdxA gene rather th...Continue Reading
References
Jun 16, 1984·Lancet·B J Marshall, J R Warren
Jan 29, 1994·Lancet·G M ForbesB J Collins
Feb 1, 1994·Journal of Clinical Microbiology·S FujimotoM J Blaser
Sep 1, 1996·Journal of Clinical Microbiology·J F WeelJ Dankert
Jun 11, 1998·Molecular Microbiology·A GoodwinP S Hoffman
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·J TankovicP J Jenks
Mar 1, 2000·Digestive Diseases and Sciences·M P DoreD Y Graham
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·D H KwonD Y Graham
Jul 29, 2000·FEMS Microbiology Letters·D H KwonD Y Graham
Aug 26, 2000·Journal of Bacteriology·J Y JeongD E Berg
Mar 27, 2001·The Journal of Antimicrobial Chemotherapy·J J KimD H Kwon
Jul 31, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N L ArentsJ G Kusters
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·D H KwonD Y Graham
Sep 15, 2001·The New England Journal of Medicine·N UemuraR J Schlemper
Jan 5, 2002·Annals of Internal Medicine·Joette M MeyerRobert J Hopkins
Feb 5, 2002·Journal of Clinical Microbiology·Seiichi KatoKazuie Iinuma
Feb 22, 2002·Alimentary Pharmacology & Therapeutics·F BazzoliE Roda
Mar 22, 2003·Research in Microbiology·Armelle MaraisFrancis Mégraud
May 10, 2003·FEMS Immunology and Medical Microbiology·Stefan BereswillManfred Kist
Citations
Jan 10, 2009·The Journal of Antibiotics·So Yeong KimJeong-Heon Cha
Aug 24, 2011·World Journal of Gastrointestinal Pathophysiology·Vincenzo De FrancescoEnzo Ierardi
Jan 29, 2016·Current Microbiology·Nasrin MirzaeiHajieh Ghasemian Safaei
Nov 23, 2006·Research in Microbiology·Fengchan HanXiaojun Yan
May 20, 2014·Helicobacter·I-Fan TuShih-Hsiung Wu
Jan 24, 2006·International Journal of Antimicrobial Agents·Mario José MatteoMariana Catalano
Aug 2, 2011·Annals of Tropical Medicine and Parasitology·N F TanihR N Ndip
Mar 1, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Cheng-Yen KaoJiunn-Jong Wu
Feb 7, 2018·Helicobacter·You-Hua WangYong Xie
Nov 21, 2019·Journal of Clinical Medicine·Nastaran FarziMohammad Reza Zali
Aug 8, 2018·Indian Journal of Medical Microbiology·Fayaz Ahmad WaniQurteeba Qadri